2026 Annual Meeting | C192 - Update in Movement Disorders
| 03:30 PM - 03:35 PM CDT | Introduction |
Opening remarks
Andres F. Deik Acosta Madiedo, MD, FAAN |
| 03:35 PM - 04:10 PM CDT | Speaker |
New medications for the treatment of movement disorders
Abhimanyu Mahajan, MD, MHS |
| 04:10 PM - 04:15 PM CDT | Q&A |
Q&A
Abhimanyu Mahajan, MD, MHS |
| 04:15 PM - 04:50 PM CDT | Speaker |
Updates in Deep Brain Stimulation for the treatment of movement disorders
|
| 04:50 PM - 04:55 PM CDT | Q&A |
Q&A
|
| 04:55 PM - 05:25 PM CDT | Speaker |
Updates in Artificial Intelligence and its application in movement disorders care
Andres F. Deik Acosta Madiedo, MD, FAAN |
| 05:25 PM - 05:30 PM CDT | Q&A |
Q&A and close
Andres F. Deik Acosta Madiedo, MD, FAAN |
| No disclosure on file | |
| Andres F. Deik Acosta Madiedo, MD, FAAN | Dr. Deik Acosta Madiedo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal Pharmaceuticals. Dr. Deik Acosta Madiedo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for SPARK-NS. Dr. Deik Acosta Madiedo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Manifold Bio. Dr. Deik Acosta Madiedo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genus Lifesciences. Dr. Deik Acosta Madiedo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Supernus Therapeutics. Dr. Deik Acosta Madiedo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amneal. The institution of Dr. Deik Acosta Madiedo has received research support from Teva Pharmaceuticals. The institution of Dr. Deik Acosta Madiedo has received research support from Cerevel Therapeutics. The institution of Dr. Deik Acosta Madiedo has received research support from Prevail Therapeutics. The institution of Dr. Deik Acosta Madiedo has received research support from Lundbeck Therapeutics. The institution of Dr. Deik Acosta Madiedo has received research support from AskBio. The institution of Dr. Deik Acosta Madiedo has received research support from Annovis Bio. The institution of Dr. Deik Acosta Madiedo has received research support from Ono pharmaceuticals. The institution of Dr. Deik Acosta Madiedo has received research support from Amylyx therapeutics. The institution of Dr. Deik Acosta Madiedo has received research support from Dystonia Coalition/Dystonia Medical Research Foundation. Dr. Deik Acosta Madiedo has received publishing royalties from a publication relating to health care. Dr. Deik Acosta Madiedo has received publishing royalties from a publication relating to health care. |
| Abhimanyu Mahajan, MD, MHS | Dr. Mahajan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vima Therapeutics, Inc.. Dr. Mahajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Adaptive Biosciences through PSG. Dr. Mahajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AskBio. Dr. Mahajan has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Movement disorders clinical practice. Dr. Mahajan has received personal compensation in the range of $500-$4,999 for serving as a Grant reviewer with Texas Alzheimer's Research And Care Consortium . |